Rawson, AshleyWilson, Amy C.Schwaderer, Andrew L.Spiwak, ElizabethJohnston, BethanneAnderson, ShannonNailescu, CorinaGupta, SushilChristenson, John C.Hains, David S.Starr, Michelle C.2021-04-092021-04-092021-01Rawson, A., Wilson, A. C., Schwaderer, A. L., Spiwak, E., Johnston, B., Anderson, S., ... & Starr, M. C. (2021). Coronavirus disease 2019 (COVID‐19) in two pediatric patients with kidney disease on chronic immunosuppression: A case series. Hemodialysis International, 25(1), E1-E5. https://doi.org/10.1111/hdi.12876https://hdl.handle.net/1805/25607This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Coronavirus disease 2019 (COVID‐19) is a highly infectious disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS‐CoV‐2). While children appear to experience less severe disease than adults, those with underlying conditions such as kidney disease may be more susceptible to infection. Limited data are present for children with kidney disease, and there are limited prior reports of pediatric hemodialysis patients with COVID‐19. This report describes the mild clinical disease course of COVID‐19 in two pediatric patients with chronic kidney disease, one on hemodialysis and both on chronic immunosuppression. We review treatment in these patients, as well as our measures to reduce transmission among our hemodialysis patients and staff.enPublic Health EmergencyCOVID-19SARS-CoV-2pediatricsArticle